Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference33 articles.
1. Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells
2. Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells
3. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
4. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
5. Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Loss of Hormone Receptor Expression after Exposure to Fluid Shear Stress in Breast Cancer Cell Lines;International Journal of Molecular Sciences;2024-06-28
2. Metabolic Signaling in Cancer Metastasis;Cancer Discovery;2024-03-29
3. The tumor-nerve circuit in breast cancer;Cancer and Metastasis Reviews;2023-03-31
4. Tea and Citrus maxima complex induces apoptosis of human liver cancer cells via PI3K/AKT/mTOR pathway in vitro;Chinese Herbal Medicines;2022-07
5. Second invasive breast cancers in patients treated with breast-conserving therapy;European Journal of Surgical Oncology;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3